Pharmascience Inc. has appointed Martin Arès as chief executive officer, effective January 3, 2023. This announcement is the outcome of an extensive search for a leader with a broad industry experience who will further energize the company for future growth and expansion.   Current Pharmascience CEO David Goodman, Ph.D., will become chair of the Board after 16 years at the helm. This transition comes at a time when Pharmascience endeavors to reinforce its position as the largest Canadian-owned...